Press Releases

| ZipLine® Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP Clinical studies continue to show shorter procedure times, fewer wound complications, reduced post-surgical care cost

download this press release as a .pdf

CAMPBELL, Calif., Jan 19, 2016—ZipLine Medical, Inc. announced it has completed a $19 million round of financing. Proceeds from the financing will be used to accelerate worldwide commercialization activities for its Zip® Surgical Skin Closure products. The financing was led

| ZipLine® Medical’s Non-invasive Zip® Surgical Skin Closure device named “2014 Best New Technology in Spine Care Winner” by Orthopedics This Week

ZipLine Medical, Inc. has been awarded “2014 Best New Technology In Spine Care” by Orthopedics This Week for the Zip® Surgical Skin Closure device. The Zip® Surgical Skin Closure was selected by a distinguished panel of 5 board-certified orthopedic and spine surgeons on the basis of its originality, clinical relevance (including would the judges use the product themselves) and likelihood of improving patient outcomes.

| ZipLine® Medical Receives CE Mark and Regulatory Approvals in Japan and South Korea for Zip® Surgical Skin Closure, Begins International Distribution

ZipLine Medical announced today that it has received CE- Mark for Europe, Todokede premarketing notification for Japan, and Korean Ministry of Food and
Drug Safety (MFDS) approval to sell its patented Zip® non-invasive surgical skin closure device. Zip® is already FDA-cleared and classified by the U.S. FDA as ‘Class I, Exempt.’